跳至主要内容
临床试验/NCT03720899
NCT03720899已完成2 期

A Pilot Trial Comparing NicoBloc to Nicotine Lozenges: Initial Acceptability and Feasibility Trial

University of Alabama at Birmingham1 个研究点 分布在 1 个国家目标入组 45 人开始时间: 2019年3月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
45
试验地点
1
主要终点
The Treatment Satisfaction Survey

研究概览

简要总结

To examine the feasibility, acceptability, and preliminary impact of using NicoBloc compared to nicotine lozenges

详细描述

Smoking remains the leading cause of preventable death in the U.S. with approximately 18% of the population continuing to smoke. However, smoking is concentrated in disadvantaged populations where the prevalence of smoking may be as high as 70-80 %. Participants will receive a sampling experience (use of nicotine lozenges or NicoBloc during sessions) with counseling focused around their experience of using these interventions, including side effects and smoking cessation expectancies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years or older
  • planning to live in the Birmingham Metro area for the next 3 months
  • Smoking at least 5 cigarettes per day for the past year and a Carbon Monoxide>8ppm to ensure daily smoking. This relatively low cutoff was chosen due to the expectation of enrolling a large >50% African-American average <10 cigarettes per day compared to Whites who average ~15 cigarettes per day
  • exclusive use of filtered cigarettes
  • English speaking.

排除标准

  • Living in a restricted environment that does not allow smoking (e.g., prison or jail facility, etc.)
  • Pregnant or nursing (all women of childbearing potential will be required to use an acceptable form of contraception)
  • Currently enrolled in a smoking cessation treatment program, using nicotine replacement products, or prescribed bupropion or varenicline
  • Known allergy nicotine lozenge
  • Within one month post-myocardial infarction or untreated severe angina
  • Cognitive impairment or unstable psychiatric condition that interferes with the informed consent process (individuals stable on psychiatric medications will be included)
  • Daily or exclusive use of other tobacco products (e.g., electronic cigarettes, little cigars, etc.).

研究组 & 干预措施

NicoBloc

Experimental

NicoBloc participants will be provided with NicoBloc to use during counseling sessions and will test smoking their conventional cigarette with NicoBloc.

干预措施: NicoBloc (Drug)

Nicotine Lozenge

Active Comparator

Participants who receive nicotine lozenge will use the lozenge in session and will discuss the effects of using the lozenge in session.

干预措施: Nicotine Lozenge (Drug)

结局指标

主要结局

The Treatment Satisfaction Survey

时间窗: 4 months

* Number of items: 10 * Scale: 1 (not at all helpful) - 7 (very helpful), as well as "0" response for "Don't Know". * Full-scale range: 0-70 * Interpretation: Higher scores indicate more treatment satisfaction Subscales: N/A

次要结局

  • Change in the Questionnaire of Smoking Urges-Brief Form, From Baseline to Week 4 Timepoint(Week 4)
  • Retention Rates(4 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karen Cropsey

Professor of Psychiatry

University of Alabama at Birmingham

研究点 (1)

Loading locations...

相似试验